Halogenated organic compounds are released widely in the environment (Monirith et al., 2003) and because of their persistent nature are of great concern to the health of humans and wildlife. These compounds are produced during the commercial production of industrial chemicals as by-products or during combustion processes (Vallack et al., 1998) . As most halogenated organic compounds are highly hydrophobic, they accumulate in the sediment of water environments near industrial zones and in the tissues (JEA, 1999) , which have high lipid content, of organisms. Of the halogenated organic compounds, the brominated compounds are produced as flame retardants (Legler and Brouwer, 2003) . Of the flame retardants, tetrabromobisphenol A has one of the highest production volumes (Birnbaum and Staskal, 2004) . Bromophenols are used as a reactive flame-retardant intermediate or as a wood preservative (WHO, 2005) . Bromophenols are also generated from the chlorination of wastewater containing bromide ions (Watanabe et al., 1984) and from the biodegradation of other brominated compounds, such as brominated benzenes and some brominated diphenyl ethers (WHO, 2005) .
To date, the effects of endocrine-disrupting chemicals on the sex steroid system have been mostly studied because of the controversy regarding the possible link between endocrinedisrupting chemicals and infertility, breast cancer, and low sperm counts in mammals including human beings. Therefore, the effects of endocrine-disrupting chemicals on the thyroid system have received comparatively little attention. However, a number of halogenated organic compounds are known to interfere with the thyroid system (Brucker-Davis, 1998) . Recent studies have indicated that brominated diphenyl ethers, bisphenols, and phenols with a greater degree of bromination were potent competitors of L-thyroxine (T 4 ) binding to human transthyretin (TTR), one of the thyroid hormone (TH)-binding proteins in plasma (Meerts et al., 2000) . These results suggested that these brominated compounds can interfere with TH homeostasis in vivo at the extracellular level of THs. Subsequent studies (Kitamura et al., 2002 (Kitamura et al., , 2005 have demonstrated that tetrabromobisphenol A, tetramethylbisphenol A, and 3,3#-dimethylbisphenol A, ranging in concentration from 10 ÿ7 to 10 ÿ4 M, acted as competitors of 3,3#,5-L-triiodothyronine (T 3 ) binding to rat thyroid hormone receptors (TRs) and that tetrabromobisphenol A exerted both T 3 agonist and antagonist activities on the T 3 -dependent cell growth and growth hormone release assays in rat GH3 cells. Although tetrabromobisphenol A (10 ÿ6 -10 ÿ5 M) also exhibited T 3 antagonist activity in a T 3 -responsive reporter gene assay using Chinese hamster ovarian cells, tetrabromobisphenol A (10 ÿ8 -10 ÿ4 M) failed to exert T 3 agonist activity in this cultured cell system (Kitamura et al., 2005) . The contradictory observations of tetrabromobisphenol A and its ability to elicit T 3 agonist activity in the two cultured cell systems are yet to be resolved.
Possible sites in the thyroid system that the organohalogens target include the thyroid gland (Collins et al., 1977) , TTR in plasma , TH metabolism (Byrne et al., 1987) , and TR-regulated gene expression (Miyazaki et al., 2004) . There are a few environmental chemicals, at concentrations less than 10 ÿ6 M, that compete with T 3 binding to the TRs (Cheek et al., 1999; Ishihara et al., 2003) . This suggests that sites in the thyroid system other than T 3 binding to the TRs are mainly targeted by the environmental chemicals, although this assumption is based on the results of in vitro studies (Cheek et al., 1999; Gauger et al., 2004; Ishihara et al., 2003; Yamauchi et al., 2003) .
In the present study, we investigated the effects of the brominated phenolic and phenol compounds on the Xenopus laevis thyroid system in vitro and in vivo. In vitro assays include the competitive interactions of the chemicals with 125 I-T 3 binding to Xenopus laevis transthyretin (xTTR) and the ligandbinding domain of X. laevis thyroid hormone receptor b (xTR LBD) and the T 3 -responsive reporter gene assay using an amphibian cell line permanently transduced with a lentiviral vector containing a T 3 -responsive luciferase gene (Sugiyama et al., 2005) . The in vivo assay was a short-term gene expression assay in a tadpole (Kudo and Yamauchi, 2005) . Of the potent chemicals detected in the in vitro assays, 3,3#,5-tribromobisphenol A exerted T 3 antagonist and agonist activities in the in vivo assay.
MATERIALS AND METHODS

Reagents.
125 I-T 3 (122 MBq/lg; carrier free) was purchased from NEN Life Science Products (Boston, MA). Unlabeled T 3 (> 98% purity) and T 4 (> 98% purity) were obtained from Sigma (St Louis, MO). 2,6-Dibromophenol (97% purity), 2,4,6-tribromophenol (97% purity), pentabromophenol (98% purity), and bisphenol A (> 98% purity) were purchased from Wako Pure Chemical Industries (Osaka, Japan). 3,3#,5,5#-Tetrabromobisphenol A (> 98% purity) was from Tokyo Kasei (Tokyo, Japan). 3-Bromobisphenol A (98% purity), 3,3#-dibromobisphenol A (98% purity), 3,5-dibromobisphenol A (98% purity), and 3,3#,5-tribromobisphenol A (98% purity) were synthesized as described below. 3,3#,5-trichlorobisphenol A (> 98% purity) was synthesized as described previously (Fukazawa et al., 2001) . AG 1-X8 resin was from BioRad (Hercules, CA). All other chemicals used in this study were either chromatography grade or the highest grade available and were purchased from either Wako Pure Chemical Industries or Nacalai Tesque (Kyoto, Japan).
All chemicals tested as thyroid system-disrupting chemicals were dissolved in dimethylsulfoxide to a concentration of 10mM. These chemicals were diluted with an appropriate buffer to give less than 0.4% (vol/vol) solvent. A control assay without the test chemicals was performed in the presence of the solvent at a concentration less than 0.4% (vol/vol). The solvent (0.4%) did not affect the competitive 125 I-T 3 -binding assays (without solvent vs. with solvent: 100.0 ± 1.5% vs. 95.4 ± 1.8%, n ¼ 3, for xTTR binding and 100.0 ± 1.2% vs. 96.8 ± 0.6%, n ¼ 3, for xTR binding) or the T 3 -responsive reporter gene assay (100.0 ± 1.7% vs. 102.8 ± 2.0%, n ¼ 3).
Synthesis of brominated derivatives of bisphenol A. A solution of bisphenol A (1.2 g) in acetone (20 ml) was added to an aqueous solution of potassium bromide (2.4 g) in water (150 ml). To this mixture, an aqueous solution of sodium hypochlorite (1%, 50 ml) was added drop by drop with stirring. The mixture was kept at about pH 3 by the addition of 1M hydrochloric acid and was stirred for 3 h. The reaction mixture was extracted with ethyl acetate. The organic solution was washed with brine and dried over anhydrous magnesium sulfate. After removal of the solvent under reduced pressure, the residue was subjected to silica gel column chromatography (20% ethyl acetate in hexane) to give 3-bromobisphenol A (270 mg), 3,3#-dibromobisphenol A (310 mg), 3,5-dibromobisphenol A (154 mg), and 3,3#,5-tribromobisphenol A (140 mg). These products were identified by nuclear magnetic resonance (NMR). NMR spectra were obtained on a JEOL JNM-GSX500 Fouriertransform spectrometer with tetramethylsilane as an internal standard.
Preparation of recombinant xTTR and xTR LBD. Recombinant xTTR and the xTR LBD-fused glutathione-S-transferase (GST) were expressed in Escherichia coli BL21 and purified from the bacterial extracts by affinity column chromatography. Recombinant xTTR was purified using human retinol-binding protein coupled to Sepharose 4B (Larsson et al., 1985) , and the GST-xTR LBD fusion protein was purified using glutathione coupled to Sepharose 4B (GE Healthcare Bio-Sciences, Piscataway, NJ) as described previously (Yamauchi et al., 2002) . SDS-PAGE showed that the purified xTTR and GST-xTR LBD fractions contained a major protein with molecular mass of 15 and 60 kDa, respectively (data not shown). Recombinant xTTR and the GST-xTR LBD fusion protein were stored in 10% glycerol at ÿ 85°C for later use. The protein concentration of recombinant xTTR and the GST-xTR LBD fusion protein was determined by the dye-binding method using bovine c-globulin as the standard (Bradford, 1976) .
125 I-T 3 binding to TTR (TTR assay) and the TR LBD (TR assay). Recombinant xTTR (70 ng per tube) or the GST-xTR LBD fusion protein (23 ng per tube) was incubated with 0.1nM 125 I-T 3 in 250 ll of the buffer (20mM Tris-HCl, pH 7.5, 93mM NaCl, and 1mM CaCl 2 for TTR assay and 10mM TrisHCl, pH 7.5, 1.5mM EDTA, 1mM dithiothreitol, and 10% [vol/vol] glycerol for TR assay) in the presence or absence of excess unlabeled T 3 for 1.0-1.5 h at 4°C, as described previously (Kudo and Yamauchi, 2005) . Competitive 125 I-T 3 binding was performed with solvent alone or increasing concentrations of the unlabeled test chemical, as described previously (Yamauchi et al., 2000) . For the TTR assay, 125 I-T 3 bound to xTTR was separated from free 125 I-T 3 by the polyethyleneglycol method (Yamauchi et al., 1993) . For the TR assay, the Dowex method (Lennon, 1992; Lennon et al., 1980) was used to separate 125 I-T 3 bound to the GST-xTR LBD protein from free 125 I-T 3 . The radioactivity of the samples was measured in a gamma counter (Auto Well Gamma System ARC-2000, Aloka, Japan). The amount of 125 I-T 3 bound nonspecifically was derived from the radioactivity of those samples incubated with excess unlabeled T 3 . The nonspecific binding value was subtracted from the amount of total bound 125 I-T 3 to give the value of specifically bound 125 I-T 3 .
T 3 -responsive reporter gene assay. Recombinant X. laevis XL58-TRE-Luc cells, which express high levels of luciferase in a T 3 -dependent manner (Sugiyama et al., 2005) , were cultured in 70% Leibovitz's L-15 medium with or without 2nM T 3 and in the absence or presence of the test chemicals at various concentrations for 24 h, following incubation in 70% Leibovitz's L-15 medium containing 10% resin-stripped fetal bovine serum (FBS) (Samuels et al., 1979) for 15 h. The cell lysate was assayed for firefly luciferase activity using the PicaGene Luminescence kit (Nippon Gene, Tokyo, Japan). The viability of the X. laevis XL58-TRE-Luc cells in the presence or absence of the test chemicals at various concentrations was photometrically examined at 450 nm using the Cell Count Reagent SF kit (Nacalai Tesque) according to the manufacturer's directions and the method described by Ishiyama et al. (1997) .
To investigate the effect of serum proteins on the T 3 agonist and/or antagonist activity of the test chemicals in the reporter gene assay, either FBS (Invitrogen, Carlsbad, CA) or bullfrog serum was added to the 70% Leibovitz's L-15 medium to a final concentration of 10%. The bullfrog serum was prepared from Rana catesbeiana tadpoles in stage X (Taylor and Kollros, 1946) , as described previously (Yamauchi et al., 2000) . In this premetamorphic stage, TTR is a major TH-binding protein in the bullfrog plasma (Yamauchi et al., 1993) . The 10% serum media were preincubated with or without T 3 in the presence or absence of the test chemicals for 6 h at 25°C before incubating the X. laevis XL58-TRE-Luc cells with the 10% serum media.
In vivo, short-term gene expression assay. Xenopus laevis tadpoles were purchased from the Xenopus Breeding Company (Tokyo, Japan). Tadpoles were classified according to the developmental stages outlined by Nieuwkoop and Faber (NF stages; 1994) . Tadpoles were maintained in a 20-l glass aquarium containing dechlorinated tap water under natural lighting conditions and were fed dried food, which was obtained commercially and is produced for the fish medaka (Medaka-no-esa, Kyorin Co., Himeji, Japan), once a week. Before starting experiments, the tadpoles were acclimatized to laboratory conditions (20-23°C) for 24 h. During the acclimatization and exposure periods, tadpoles were not fed. Five to six tadpoles per group in NF stages 52-53 were transferred to a 1-l glass beaker containing 0.5-0.6 l of FETAX buffer (Dumont et al., 1983 ). An in vivo, short-term gene expression assay was performed according to the protocol outlined previously (Kudo and Yamauchi, 2005) except that the exposure period was altered. In brief, after tadpoles were exposed to the solvent alone or the test chemicals dissolved in the solvent in the presence or absence of 2nM T 3 for 2 days, anesthetized in 0.02% 3-aminobenzoic acid ethyl ester (Sigma), and dissected into head, trunk, and tail regions. Each region was frozen separately in liquid nitrogen and then stored at ÿ 80°C until RNA preparation. Each experiment was repeated at least twice using tadpoles from different sets of adults.
Real-time PCR. Total RNA was extracted from the frozen head and trunk regions of tadpoles using the LiCl-urea procedure (Auffray and Rougeon, 1980) . The amounts of specific RNA transcripts were estimated by real-time PCR using the SYBR Green Master Mix and the ABI Prism 7000 (Applied Biosystems, Foster City, CA) after the RNA samples were treated with reverse transcriptase (TaqMan Reverse Transcription Reagents, Applied Biosystems), as described previously (Kudo and Yamauchi, 2005) . Each PCR was run in triplicate to control for PCR variation. To standardize each experiment, the amount of each T 3 -responsive gene transcript was divided by the amount of glyceraldehydephosphate dehydrogenase RNA in the same sample. The primer sequences used to amplify the X. laevis glyceraldehydephosphate dehydrogenase and TRb transcripts were shown in a previous report (Kudo and Yamauchi, 2005) . The primer sequences used to amplify the X. laevis TH/bZIP transcript (accession number: U41859) are sense 5#-GTTTCCGTTTTGGCCTGGTA-3# (nucleotide numbers 413-432) and antisense 5#-CATGAAGGCCACACT-GTGTTG-3# (487-467).
Statistical analysis. The data are presented as mean ± SEM. Differences between two groups were analyzed with Student t test following Bartlett's test for uniformity of variances. Data from reporter gene assay were analyzed by a one-way or a two-way ANOVA with the Fisher least significant difference test for multiple comparisons, to evaluate the significance of the differences. p < 0.05 was considered statistically significant.
RESULTS
Effect of Brominated Phenolic and Phenol Compounds on 125 I-T 3 Binding to xTTR
To determine which brominated compounds were strong competitors of 125 I-T 3 binding to xTTR, 125 I-T 3 binding to xTTR was examined in the presence of the phenolic (Fig. 1A) and phenol (Fig. 1B) compounds at various concentrations. Of bisphenol A and its brominated derivatives, 3,3#,5-tribromobisphenol A was the most powerful competitor of 125 I-T 3 binding to xTTR with a 50% inhibitory concentration (IC 50 ) of 1.12 ± 0.10nM. The relative affinities of 3,3#,5-tribromobisphenol A, 3,3#-dibromobisphenol A (IC 50 ¼ 1.80 ± 0.69nM), and 3,3#,5,5#-tetrabromobisphenol A (IC 50 ¼ 3.07 ± 0.29nM) for xTTR were three orders of magnitude greater than that of bisphenol A (IC 50 ¼ 1670 ± 30nM) and were also greater than that of T 3 (IC 50 ¼ 6.46 ± 0.03nM). The relative affinity of 3,3#,5-tribromobisphenol A for xTTR was twofold greater than that of 3,3#,5-trichlorobisphenol A (IC 50 ¼ 2.22 ± 0.09nM), which was previously identified as a potent competitor of 125 I-T 3 binding to xTTR (Kudo and Yamauchi, 2005) . Of the bromophenols tested, pentabromophenol was the most potent competitor with an IC 50 of 363 ± 32nM, but the relative affinity of this compound for xTTR was two orders of magnitude less than that of T 3 . effect on 125 I-T 3 binding to xTTR (Fig. 1) . The compounds with an IC 50 of less than 10 ÿ6 M were 3,3#-dibromobisphenol A (360 ± 50nM) and 3,3#,5-tribromobisphenol A (790 ± 10nM). The relative affinities of the two compounds for xTR were still several hundred fold less than that of T 3 (IC 50 ¼ 1.33 ± 0.02nM). The relative affinity of 3,3#,5-tribromobisphenol A for xTTR was threefold greater than that of 3,3#,5-trichlorobisphenol A (IC 50 ¼ 2220 ± 90nM). The rank order-binding affinities of the brominated phenolic and phenol compounds for xTR were similar to those for xTTR.
Effect of Brominated
Effect of Brominated Phenolic and Phenol Compounds on
T 3 -Responsive Reporter Gene Assay in a Recombinant X. laevis Cell Line
We investigated the effect of the brominated phenolic and phenol compounds on a T 3 -responsive reporter gene assay in the recombinant X. laevis cell line, XL58-TRE-Luc. In the absence of the brominated phenolic and phenol compounds, T 3 (2nM) increased the luciferase activity by about threefold. Cotreatment of 3,3#-dibromobisphenol A, 3,3#,5-tribromobisphenol A, or 3,3#,5,5#-tetrabromobisphenol A with T 3 significantly inhibited the T 3 -induced luciferase activity in a dose-dependent manner, demonstrating their T 3 antagonist activity (Fig. 3A) . The mean inhibition percentage obtained from independent repeated experiments (n ¼ 3) was 85 ± 5% for 0.1lM 3,3#-dibromobisphenol A ( p < 0.05 compared with control), 67 ± 9% for 0.1lM 3,3#,5-tribromobisphenol A ( p < 0.01), and 67 ± 8% for 0.1lM 3,3#,5,5#-tetrabromobisphenol A ( p < 0.05). The effect of other compounds tested on the luciferase activity was small or not significant although 3-bromobisphenol A and 3,5-dibromobisphenol A had a tendency to inhibit the T 3 -induced luciferase activity in a dose-dependent manner. When the cells were exposed to these compounds in the absence of T 3 (Fig. 3B) , the luciferase activity increased significantly by 121 and 129% in the presence of 3,3#,5-tribromobisphenol A ( p < 0.05 at 0.01lM; p < 0.01 at 0.1 and 1.0lM) and 3,3#,5,5#-tetrabromobisphenol A ( p < 0.01 at 0.1 and 1.0lM), respectively, demonstrating that 3,3#,5-tribromobisphenol A and 3,3#,5,5#-tetrabromobisphenol A had T 3 agonist activity. Other compounds had little or no effect on the luciferase activity even though 3,5-dibromobisphenol A and 3,3#-dibromobisphenol A had a tendency to increase the luciferase activity in a dose-dependent manner. Cell viability was not compromised in the presence of all chemicals (0.5-4lM) tested except for pentabromophenol, which was cytotoxic at 0.5lM (Fig. 3C) .
Effect of Serum Proteins on T 3 Agonist and Antagonist Activities of the Compounds in a Recombinant X. laevis Cell Line
To determine the extent with which serum proteins affected T 3 agonist and antagonist activities of the brominated phenolic and phenol compounds in XL58-TRE-Luc cells, we conducted the reporter gene assay in the absence or presence of 10% serum (FBS and bullfrog tadpole serum) and examined the T 3 agonist and antagonist activities of 3,3#,5-tribromobisphenol A (Figs. 4A and 4B ) and o-t-butylphenol (Figs. 4C and 4D ). In the 3,3#,5-tribromobisphenol A treatment, dose effects on T 3 agonist (Fig. 4A) and antagonist (Fig. 4B ) activities were significant compared with control ( p < 0.05 at 0.1lM). Serum effects on T 3 agonist (Fig. 4A) and antagonist (Fig. 4B ) activities were significant in FBS ( p < 0.05) and in both FBS and bullfrog serum ( p < 0.01), respectively. In the o-tbutylphenol treatment, T 3 agonist activity was not detected (Fig. 4C ), but T 3 antagonist activity was detected (Fig. 4D ). Dose effect on T 3 antagonist activity (Fig. 4D ) was significant ( p < 0.01 at 1.0 and 10lM); however, no serum effect on T 3 antagonist activity (Fig. 4D) was detected. These results demonstrated that the serum proteins in the culture medium weakened both T 3 agonist and antagonist activities of 3,3#,5-tribromobisphenol A but did not influence the T 3 antagonist activity of o-t-butylphenol.
Effect of 3,3#,5-Tribromobisphenol A on Short-Term Gene Expression in X. laevis Premetamorphic Tadpoles
In the trunk and head regions of X. laevis tadpoles treated with T 3 (2nM), the amount of the TRb gene transcript increased 23-and 9-fold, respectively, whereas the amount of the TH/bZIP gene transcript increased 42-and 13-fold, respectively, on the second day after treatment (Figs. 5B and 5D) . Treatment of the tadpoles with 0.5lM 3,3#,5-tribromobisphenol A in the absence of T 3 significantly increased the amounts of the TRb and TH/bZIP gene transcripts by 200% ( p < 0.05) and 198% ( p < 0.05) of the control, respectively, in the trunk (Fig. 5A ), but not in the head where they were 122 and 95% of the control, respectively (Fig. 5C ). In the trunk of tadpoles cotreated with 0.5lM 3,3#,5-tribromobisphenol A and T 3 , the T 3 -induced increase in the amount of the TH/bZIP gene transcript was significantly inhibited and was 61% of the control ( p < 0.05), whereas the T 3 -induced increase in the amount THYROID-DISRUPTING ACTIVITY OF BROMINATED COMPOUNDS of the TRb gene transcript was not significantly inhibited and was 67% of the control (Fig. 5B) . In the head of tadpoles, cotreatment of 0.5lM 3,3#,5-tribromobisphenol A with T 3 did not significantly affect the T 3 -induced increase in the amount of the two transcripts, which were 62-63% of the control (Fig. 5D) . These results demonstrated that 3,3#,5-tribromobisphenol A elicited T 3 agonist and antagonist activities in at least the trunk region of X. laevis premetamorphic tadpoles.
DISCUSSION
The present study demonstrated that 3,3#,5-tribromobisphenol A exhibited both T 3 agonist and antagonist activities at submicromolar concentrations in a X. laevis cell line and X. laevis tadpoles. This compound competed with T 3 binding to xTTR and xTR in vitro, suggesting that xTTR and xTR are possible target sites for 3,3#,5-tribromobisphenol A. These results raised the possibility that the flame retardant 3,3#,5-tribromobisphenol A interferes with extracellular TH homeostasis by binding TTR, which is a major TH-binding protein in amphibian tadpoles (Yamauchi et al., 1993) , and with the intracellular TH-signaling pathway by binding TR.
Our previous studies on the competitive inhibition of 125 I-T 3 binding to TTRs and TRs revealed a structure-activity relationship between the chlorinated compounds and THs (Kudo and Yamauchi, 2005; Yamauchi et al., 2003) . These studies revealed that (1) generally, the relative potency of the chlorinated phenolic and phenol compounds with which they interfered with 125 I-T 3 binding to TTRs and TRs was dependent upon the degree of chlorination of the compound; (2) TRs from amphibians and chicken and TTRs from amphibians preferentially bind compounds with structures that are similar to T 3 , such as chlorinated phenolic compounds that have two phenolic rings with chlorines in either ortho positions with respect to the hydroxy group, e.g., 3,3#-dichlorobisphenol A and 3,3#,5-trichlorobisphenol A, whereas TTR from chicken preferentially binds phenolic compounds with structures that are similar to T 4 , such as chlorinated phenolic compounds that have two phenolic rings with chlorines in both ortho positions with respect to the hydroxy group, e.g., 3,3#,5,5#-tetrachlorobisphenol A; and (3) the affinity of the chlorinated phenolic and phenol compounds for TRs were three orders of magnitude less than that of T 3 , whereas the affinity of the chlorinated phenolic and phenol compounds for TTRs were comparable with that of T 3 . Thus, it was concluded that the binding preferences of TTR and TR for particular chlorinated phenolic compounds may reflect the TH-binding properties of TTR and TR and the structural resemblance between the chlorinated phenolic compounds and THs. This conclusion is particularly relevant given that mammalian TTRs have a four-to eightfold higher affinity for T 4 than T 3 (Chang et al., 1999; Robbins, 1996) , whereas xTTR and the bullfrog TTR have a 100-to 400-fold higher affinity for T 3 than T 4 (Yamauchi et al., 1993 (Yamauchi et al., , 2002 . The structure-activity relationship identified for the chlorinated compounds and THs may also be true for the binding of the brominated compounds to X. laevis and human TTRs (this study; Meerts et al., 2000) and TRs (this study; Kitamura et al., 2002) . In addition to these studies, the present and previous studies (Kudo and Yamauchi, 2005) found that xTTR, like human TTR (Meerts et al., 2000) , had several times higher affinity for the brominated derivatives of bisphenol A than for the chlorinated derivatives of bisphenol A, whereas xTTR, unlike human TTR (Meerts et al., 2000) , had several times lower affinity for the bromophenols than for the chlorophenols. These binding characteristics suggest that generally a structureactivity relationship exists between the structurally related, halogenated compounds and THs. It should be noted that there are species differences in TH-binding proteins. TTR is a relatively minor binding protein in human plasma but a major binding protein in amphibian plasma (Schreiber and Richardson, 1997) . This raises the possibility that some halogenated compounds affect plasma TH homeostasis in a species-specific manner by binding TTR.
The T 3 -responsive reporter gene assay using the recombinant X. laevis cell line XL58-TRE-Luc revealed T 3 agonist and antagonist activities of both 3,3#,5-tribromobisphenol A and 3,3#,5,5#-tetrabromobisphenol A at 10 ÿ7 -10 ÿ6 M. The effective concentrations of 3,3#,5-tribromobisphenol A and 3,3#,5,5#-tetrabromobisphenol A in the T 3 -responsive reporter gene assay corresponded well to those recorded for the inhibition of 125 I-T 3 binding to xTR. Therefore, it is highly likely that these compounds exerted T 3 agonist and antagonist activities by binding to xTR. Recently, it has been reported that some lipophilic chemicals accumulate into cultured cells by one to two orders of magnitude in tissue-, time-, and concentration-dependent manners (Maecham et al., 2005) . It is likely that the lipophilicity, cellular influx or efflux by specific transporters, metabolism of a compound (Wong et al., 2005) and the presence of high-affinity binding sites other than the T 3 -binding site of the TR for a compound would affect its intracellular free concentration or its action through the TR-coregulator complex. Our findings do not exclude the possibility that 3,3#,5-tribromobisphenol A and 3,3#,5,5#-tetrabromobisphenol A target an intracellular process other than T 3 binding to the TR that disrupts the thyroid system. Recent studies have demonstrated that bisphenol A interfered with the thyroid system by recruiting the nuclear corepressor to the human TR (Moriyama et al., 2002) and that some hydroxylated polychlorinated biphenyls caused the partial dissociation of the TR/retinoid X receptor heterodimer complex from the TH-responsive elements (Miyazaki et al., 2004) . The concentrations of bisphenol A (0.1-1.0lM) and hydroxylated polychlorinated biphenyls (0.1pM) required to elicit T 3 antagonist activity were several orders of magnitude lower than their IC 50 values for competitive binding to the human TR (Cheek et al., 1999; Moriyama et al., 2002) . This indicated that bisphenol A and the hydroxylated polychlorinated biphenyls affected TR activation without displacing T 3 from the TR. A recent review (Tabb and Blumberg, 2006) proposed several novel modes by which environmental chemicals could disrupt the steroid system that included the modulation of the proteasomemediated degradation of nuclear receptors and their coregulators, inhibition of histone deacetylase activity, and stimulation of mitogen-activated protein kinase activity. In the thyroid system, it remains to be clarified whether environment chemicals disrupt processes of gene transcription other than T 3 binding to the TRs.
In our reporter gene assay using an in vitro cell culture system, we found that serum proteins were capable of weakening T 3 agonist and antagonist activities of 3,3#,5-tribromobisphenol A. However, serum proteins did not influence T 3 antagonist activity of o-t-butylphenol. Considering the fact that 3,3#,5-tribromobisphenol A had an affinity that was three orders of magnitude higher for xTTR than that of o-t-butylphenol ( Fig. 1 and Kudo and Yamauchi, 2005) , TTR may selectively influence the cellular action of the thyroid system-disrupting chemicals depending upon its affinity for chemicals.
Our in vivo, short-term gene expression assay in tadpoles confirmed that 3,3#,5-tribromobisphenol A elicited T 3 agonist and antagonist activities. As the TH/bZIP gene was induced with greater extent than the THb gene by treatment with T 3 in the trunk and head, the TH/bZIP gene may be a suitable molecular marker for detecting thyroid system-disrupting chemicals. The amphibian metamorphosis-based assays conducted by other groups (Jagnytsch et al., in press; Kitamura et al., 2005) revealed T 3 antagonist and/or agonist activities of 3,3#,5,5#-tetrabromobisphenol A. However, the effect of 3,3#,5-tribromobisphenol A in our in vivo, short-term gene expression assay in premetamorphic tadpoles was not as clear as that found in the in vitro assay using the cell line (Fig. 5 vs.  Figs. 3 and 4) . The thyroid system-disrupting activity of 3,3#,5-tribromobisphenol A was barely detected in the X. laevis trunk and was not detected in the head. Therefore, the sensitivity of different tissues to THs, the endpoints investigated, the developmental stage selected (OECD, 2004) , the modulation of the effect of the chemical by plasma proteins including TTR, and the variation in the response to THs among individual tadpoles (Turque et al., 2005) may all be important factors for clearly detecting and identifying the thyroid system-disrupting activity of the environmental chemicals in in vivo studies.
The thyroid system-disrupting activity of 3,3#,5-tribromobisphenol A identified in our in vitro reporter gene assay and in vivo, short-term gene expression assay was acute. We cannot fully determine to what extent the thyroid system-disrupting activity of 3,3#,5-tribromobisphenol A is modulated by plasma in vivo and what impact this chemical has on the amphibian thyroid system after long-term exposure. The in vivo situation in tadpoles after their long-term exposure to environmental chemicals for which TTR has a high affinity may be close to the situation found in wildlife chronically exposed to halogenated persistants, such as the polychlorinated biphenyls. A negative correlation between polychlorinated biphenyls and TH levels has been found in the plasma of seals (Chiba et al., 2001 ) and polar bears (Braathen et al., 2004) . However, data are very limited regarding the presence of brominated derivatives of bisphenol A in biota. Serum levels of tetrabromobisphenol A ranged from 1 to 3.4 pmol/g lipid in human (Jakobsson et al., 2002) . In tadpoles, the dynamic destination of 3,3#,5-tribromobisphenol A, the half-life of TTR in vivo, the expression level of TTR, and the plasma levels of THs after exposure to 3,3#,5-tribromobisphenol A remains to be clarified.
